KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Prepaid Assets (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Prepaid Assets for 13 consecutive years, with $10.4 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 50.83% to $10.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Dec 2025, up 50.83% year-over-year, with the annual reading at $10.4 million for FY2025, 50.83% up from the prior year.
  • Prepaid Assets for Q4 2025 was $10.4 million at Xenon Pharmaceuticals, down from $17.1 million in the prior quarter.
  • The five-year high for Prepaid Assets was $17.1 million in Q3 2025, with the low at $2.9 million in Q2 2023.
  • Average Prepaid Assets over 5 years is $6.3 million, with a median of $5.2 million recorded in 2022.
  • The sharpest move saw Prepaid Assets crashed 58.53% in 2023, then skyrocketed 264.0% in 2025.
  • Over 5 years, Prepaid Assets stood at $4.5 million in 2021, then soared by 61.24% to $7.2 million in 2022, then fell by 16.87% to $6.0 million in 2023, then grew by 14.72% to $6.9 million in 2024, then surged by 50.83% to $10.4 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $10.4 million, $17.1 million, and $11.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.